Cited by 78Advanced Drug Delivery SystemsAntibiotics Pharmacokinetics and EfficacyNanoparticle-Based Drug Delivery

Future challenges for drug delivery.

Breimer, D.D·1999·Journal of Controlled Release

Integrity signals

Registry

Crossref · 10.1016/s0168-3659(99)00060-7

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Unfavorable GC pharmacokinetics can be overcome by a drug delivery system providing slow zero-order release kinetics that keeps plasma drug concentration below toxicity while allowing the drug concentration needed for therapeutic effect.

    “This unfavorable pharmacokinetics can be overcome by the use of a drug delivery system (DDS) providing a slow, zero-order release kinetics that, while keeping plasma drug concentration below toxicity level, will allow for the drug concentration needed to achieve a therapeutic effect [5].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Breimer, D. D.
Affiliations
Leiden University (NL)
Corresponding author
Breimer, D.D
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
1999-11
Volume
62
Issue
1-2
Pages
3-6
ISSN
0168-3659 (ISSN-L)
OpenAlex
W1993413788
Cited by
78
References
8
Citations by year
2026: 1 · 2023: 1 · 2022: 1 · 2019: 3 · 2018: 2 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 9 · 2012: 5
FWCI
2.11
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Controlled Release (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Pharmacology › Antibiotics Pharmacokinetics and Efficacy
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
drug delivery systems, anti-infective agents, antimicrobial resistance, pharmacokinetics, pharmacodynamics, in vitro drug release, time-kill assay, pharmaceutical dosage forms, bioavailability
MeSH terms
Humans, Netherlands, Drug Delivery Systems, Treatment Outcome, Economics, Pharmaceutical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review